|ECR 2019 / C-2520||
|Radiological approach to thoracic immune-related adverse events in cancer treatment|
- The role of the radiologist in the diagnostic approach and monitoring to thoracic immune-related adverse events is essential.
- HRCT is the preferred diagnostic study when pulmonary immune-related toxicity is suspected.
- Optimal patient care during immunotherapy requires multidisciplinary effort by pulmonologists, medical oncologists, and radiologists.
Thematically related posters
ECR 2019 / C-1319
Checkpoint inhibitor related adverse events: what the radiologist should be aware of